170 related articles for article (PubMed ID: 12907899)
1. Tumor budding at the invasive margin can predict patients at high risk of recurrence after curative surgery for stage II, T3 colon cancer.
Tanaka M; Hashiguchi Y; Ueno H; Hase K; Mochizuki H
Dis Colon Rectum; 2003 Aug; 46(8):1054-9. PubMed ID: 12907899
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor "budding" in patients with colorectal cancer.
Hase K; Shatney C; Johnson D; Trollope M; Vierra M
Dis Colon Rectum; 1993 Jul; 36(7):627-35. PubMed ID: 8348847
[TBL] [Abstract][Full Text] [Related]
4. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma.
Park KJ; Choi HJ; Roh MS; Kwon HC; Kim C
Dis Colon Rectum; 2005 Aug; 48(8):1597-602. PubMed ID: 15937624
[TBL] [Abstract][Full Text] [Related]
5. Tumor budding and survival after potentially curative resection of node-positive colon cancer.
Sy J; Fung CL; Dent OF; Chapuis PH; Bokey L; Chan C
Dis Colon Rectum; 2010 Mar; 53(3):301-7. PubMed ID: 20173477
[TBL] [Abstract][Full Text] [Related]
6. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence.
Burdy G; Panis Y; Alves A; Nemeth J; Lavergne-Slove A; Valleur P
Dis Colon Rectum; 2001 Nov; 44(11):1682-8. PubMed ID: 11711742
[TBL] [Abstract][Full Text] [Related]
7. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
8. Perineural Invasion is a Major Prognostic and Predictive Factor of Response to Adjuvant Chemotherapy in Stage I-II Colon Cancer.
Cienfuegos JA; Martínez P; Baixauli J; Beorlegui C; Rosenstone S; Sola JJ; Rodríguez J; Hernández-Lizoáin JL
Ann Surg Oncol; 2017 Apr; 24(4):1077-1084. PubMed ID: 27624582
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting local recurrence of colonic adenocarcinoma.
Harris GJ; Church JM; Senagore AJ; Lavery IC; Hull TL; Strong SA; Fazio VW
Dis Colon Rectum; 2002 Aug; 45(8):1029-34. PubMed ID: 12195186
[TBL] [Abstract][Full Text] [Related]
10. Histopathological Predictors of Recurrence in Stage III Colon Cancer: Reappraisal of Tumor Deposits and Tumor Budding Using AJCC8 Criteria.
Landau MA; Zhu B; Akwuole FN; Pai RK
Int J Surg Pathol; 2019 Apr; 27(2):147-158. PubMed ID: 29992847
[TBL] [Abstract][Full Text] [Related]
11. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer.
Jäger T; Neureiter D; Fallaha M; Schredl P; Kiesslich T; Urbas R; Klieser E; Holzinger J; Sedlmayer F; Emmanuel K; Dinnewitzer A
Strahlenther Onkol; 2018 Nov; 194(11):991-1006. PubMed ID: 30069738
[TBL] [Abstract][Full Text] [Related]
12. Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.
Konishi T; Shimada Y; Lee LH; Cavalcanti MS; Hsu M; Smith JJ; Nash GM; Temple LK; Guillem JG; Paty PB; Garcia-Aguilar J; Vakiani E; Gonen M; Shia J; Weiser MR
Am J Surg Pathol; 2018 Jun; 42(6):705-714. PubMed ID: 29624511
[TBL] [Abstract][Full Text] [Related]
13. Tumour budding in preoperative biopsy specimens is a useful prognostic index for identifying high-risk patients in early-stage (pN0) colon cancer.
Zengin M; Çifci A
Turk J Med Sci; 2020 Apr; 50(2):375-385. PubMed ID: 32011836
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of tumor budding in a thoroughly characterized stage II colon cancer population in the context of a national screening program.
Pihlmann Kristensen M; Korsgaard U; Timm S; Hansen TF; Zlobec I; Hager H; Kjær-Frifeldt S
Hum Pathol; 2024 Apr; 146():15-22. PubMed ID: 38428823
[TBL] [Abstract][Full Text] [Related]
15. Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
Osterman E; Glimelius B
Dis Colon Rectum; 2018 Sep; 61(9):1016-1025. PubMed ID: 30086050
[TBL] [Abstract][Full Text] [Related]
16. Improved prediction of recurrence after curative resection of colon carcinoma using tree-based risk stratification.
Radespiel-Tröger M; Hohenberger W; Reingruber B
Cancer; 2004 Mar; 100(5):958-67. PubMed ID: 14983491
[TBL] [Abstract][Full Text] [Related]
17. Tumour budding is a reproducible index for risk stratification of patients with stage II colon cancer.
Lai YH; Wu LC; Li PS; Wu WH; Yang SB; Xia P; He XX; Xiao LB
Colorectal Dis; 2014 Apr; 16(4):259-64. PubMed ID: 24118729
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
19. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of p27, p53, and vascular endothelial growth factor in Dukes A and B colon cancer patients undergoing potentially curative surgery.
Galizia G; Ferraraccio F; Lieto E; Orditura M; Castellano P; Imperatore V; Romano C; Vollaro M; Agostini B; Pignatelli C; De Vita F
Dis Colon Rectum; 2004 Nov; 47(11):1904-14. PubMed ID: 15622584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
